Use of a toll-like receptor 9 (tlr9) agonist and a tlr2/6 agonist for the preparation of a medicament and a pharmaceutical composition comprising the same

摘要

Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a StIR composition to the individual.